Abstract: The invention relates to a packaging unit for homogenising ceramic slurry in mixing devices with at least one packaging vessel, which exhibits a releasable closure, containing ceramic slurries or their components in pre-metered quantities.

Abstract: A polymerizable dental material formed of a liquid component containing A) at least one liquid methyl methacrylate monomer component, B) at least one acrylated or methacrylated butadiene oligomer or acrylated or methacrylated butadiene polymer and/or an acrylated or methacrylated acrylonitrile-butadiene oligomer or acrylated or methacrylated acrylonitrile-butadiene polymer, and optionally a powder component containing a polymer powder or a bead polymer based on methacrylate.

Abstract: Dental materials with high abrasion resistance and their use for producing artificial teeth and/or their enamel or cutting areas are described. The materials primarily contain: (a) Monofunctional meth-/acrylates ?20-50% (b) Crosslinking meth-/acrylate ??1-20% (c) Splitter polymer from components (2) and (5) ??2-30% (d) PMMA-pearl polymers, partly crosslinked ??2-50% (e) Pyrogenic silicic acid, silanated ??0-20% (f) Inorganically fortified pearl polymer ??5-50% (g) Initiator components 0.1-1% (h) Coloring pigments 0.1-3%.

Abstract: A surgical suture material with an antimicrobial surface is described, the surface exhibiting a coating containing a) at least one fatty acid, b) octenidine dichloride and/or dequalinium chloride and c) optionally oligomeric lactic acid esters. In addition, a process for coating surgical suture material is described which is characterized by the fact that the thread material is wetted with a homogeneous methanolic solution of octenidine dichloride and/or dequalinium chloride and subsequently the methanol is evaporated, a coating forming on the thread surface.

Abstract: Prosthesis material having improved stability during storage, reduced plaque affinity and improved polishing properties.

Abstract: The invention relates to a method for the antibiotic coating of bodies with interconnecting microcavities as well as bodies coated this way and their usage.

Abstract: The invention relates to hardly soluble antiphlogistic salts and antiphlogistic-antibiotic pharmaceutical preparations and their use. The hardly water soluble antiphlogistic antibiotics salts have as their cationic component one of the antibiotics gentamicin, clindamycin, neomycin, streptomycin, tetracycline, doxicyline, oxytetracycline and rolitetracycline and as their anionic component one of the antiphlogistics ibuprofen, naproxen, indomethacin, dexamethasone-21-phosphate, dexamethasone-21-sulfate, triamcinolone-21-phosphate and triamcinolone-21-sulfate. The antiphlogistic antibiotics salts are used in pharmaceutical preparations as controlled-release antibiotic/antibiotics drugs.

Abstract: The present invention relates to an antibiotic(s)-polymer combination, which under physiological conditions guarantees the continuous release of antibiotics over a period of several days and can be used in human and veterinary medicine. The invented antibiotic(s)-polymer combination is wherein in a homogeneous polymer mixture, consisting of one or more hydrophobic polymers from the groups of poly(methacrylic acid esters), the poly(acrylic acid esters) and the poly(methacrylic acid ester-co-acrylic acid esters) and one or more hydrophilic polymers from the group of polyethers, one or more slightly water-soluble antibiotics from the groups of aminoglycoside antibiotics, the lincosamide antibiotics, the tetracycline antibiotics and quinolone antibiotics, possibly an easily water-soluble antibiotic from the groups of aminoglycoside antibiotics, the lincosamide antibiotics and the tetracycline antibiotics, and possibly one or more organic adjuvants are suspended, and that this suspension forms a composite.

Abstract: A bone replacement material that is, in particular, paste-like and is characterized in that particulate calcium carbonate is suspended in an aqueous solution that contains at least one water-soluble hemostatic agent, whereby the aqueous solution contains an amount of the hemostatic agent at which it is isotonic.

Abstract: A dental implant system component having a coating made of an only slightly water-soluble chlorhexidine fatty acid salt, in which one or more antiphiogistics and/or one or more steroids and/or one or more prostaglandins and/or one or more bisphosphonates and/or one or more statins are dissolved.

Abstract: A post-shaped element for determining the alignment of an implant (10), or the opening cross-section of an artificial indentation located in a tooth or in the stroma of a human or animal body, relative to the surrounding tissue structures, can be introduced with a receiving section (28, 26A) into an adapted receiving recess (10) in the implant (1) or the artificial indentation, and be affixed therein and removed again. In a connecting position the post-shaped element protrudes with a cantilever section (26K) beyond the opening cross-section of the receiving recess (10) or the artificial indentation.

Abstract: The present invention relates to a method for manufacturing dental prostheses according to a digitized virtual model which reflects the maximally situation, comprising the steps providing a data record that reflects the maxillary situation and relationship, digital modeling of the tooth, creating a divided negative mold (rapid manufacturing) from the data from the digital tooth modeling, insertion of the fabricated teeth into the opened negative mold, closing the negative mold, filling the remaining cavity with plastic for the prosthesis.

Abstract: A dental kit made up of: A at least one pre-shaped dental crown made from a plastically deformable dental composite material curable by light, B a container impermeable to light, in which the pre-shaped dental crown is kept before it is applied to a tooth stump, C optionally a film which covers the outer surface of the pre-shaped dental crown.

Abstract: One or more substances of the group consisting of gentamicin palmitate, gentamicin myristate, gentamicin laurate, tobramycin palmitate, tobramycin myristate, tobramycin laurate, amikacin palmitate, amikacin myristate, amikacin laurate, vancomycin palmitate, vancomycin laurate, and vancomycin myristate are suitable for providing vascular grafts with an antithrombogenically active principle.

Abstract: Described is a method for producing a dental prosthesis, comprising the following steps: A Producing a model from a material which does not bond with the dental prosthesis material, B Fixing the teeth, C Filling the interspace between the artificial tooth/teeth and the model, wherein in step C melted thermoplastic material is applied in layers and after each layer is hardened by cooling.

Abstract: The invention relates to a self-curing two-component dental material having as its components A powder component containing dicalcium phosphate anhydrate (DCPA) or dicalcium phosphate dihydrate (DCPD) and tetracalcium phosphate (TTCP) and B liquid component containing water and complexing agent, whereby crystalline DCPA having a crystal shape of small plates typical of brushite having an iron (Fe), manganese (Mn), molybdenum (Mo), and tungsten (W) content of less than 0.2 m % (200 ppm) each is used.

Abstract: Disclosed are polymerizable dental materials containing silver particles having a primary particles diameter <40 nm as an antimicrobidal additive. The inventive dental materials are suitable as filling composites, basic prosthetic materials, adhesives, coating composites for crowns and bridges, and materials for artificial teeth, for example.

Abstract: Form bodies, which can be rotationally-symmetrical or irregularly-shaped, consist of at least one member of the group of the antibiotic salts, gentamicin myristate, gentamicin palmitate, gentamicin stearate, tobramycin myristate, tobramycin palmitate, tobramycin stearate, amikacin myristate, amikacin palmitate, amikacin stearate, vancomycin palmitate, vancomycin stearate, ramoplanin palmitate, ramoplanin stearate, levofloxacin palmitate, levofloxacin stearate, ofloxacin palmitate, ofloxacin stearate, moxifloxacin palmitate, moxifloxacin stearate, clindamycin palmitate, and clindamycin stearate. A medical device for implantation, in which the form bodies are arranged on a biodegradable filament at a distance of 1 mm to 25 mm as well as a method for the manufacture of the medical device and the use of the form bodies or the medical device to treat chronic osteomyelitis are described.

Abstract: A local system for the release of active principle is described which consists of approximately spherical or rotation symmetrical bodies which are composed essentially of polymethyl methacrylate or polymethyl methacrylate co-methyl acrylate, zirconium dioxide or barium sulphate and one or more pharmaceutical active principles, in particular antibiotics, and which are produced by radical polymerisation, radical polymerisation activators effective in the temperature range of 10-80° C. or residues of these polymerisation activators from the groups of aromatic amines, heavy metal salts and barbiturates not being contained therein.

Abstract: A self-curing or dual-curing, low viscosity composite is used for the fabrication of a dental liner capable of polymerization in 2 stages with 2 curing times and delayed polymerization characteristics that is designed for use at the cavity wall in the form of a thin layer.